CO.DON is a biopharmaceutical company and manufacturer of cell transplants. With more than 25 years of experience in tissue engineering, the focus is on the development, production and marketing of regenerative, joint-preserving cell therapies for the treatment of cartilage defects in joints with the body’s own cells.
Get exclusive monthly insights into our use cases, activities and news from the network - Register now for free.
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.